XPH SPDR S&P Pharmaceuticals ETF Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
07:05
Sep 15
Bloomberg Markets
Rotate from chips into healthcare/pharma.
Investors are rotating out of US semiconductor/chip ETFs as AI enthusiasm cools, and the healthcare sector, particularly pharma, is emerging as a winner of that rotation according to sector trackers.
XPH SPDR S&P Pharmaceuticals ETF Long 1ST — —
16:00
Mar 29
El Arte de Invertir
Pharma is defensive and cheaply valued.
The speaker notes pharmaceutical companies have lagged the bull market, leaving valuations around 11-14x earnings versus about 20x for the S&P 500, while demand for medicines is defensive and should persist even through geopolitical conflict or higher oil. He flags the sector as interesting and worth researching.
XPH SPDR S&P Pharmaceuticals ETF Long 1ST — —
16:28
Mar 02
Bloomberg Markets
RBC is "overweight" the Healthcare sector. Calvasina notes that during oil crises, "both the pharma group and the health care equipment and services group tend to outperform." When geopolitical risk rises, capital rotates out of high-beta tech and into defensive sectors with stable earnings. Healthcare offers a dual benefit: it acts as a safe haven (defensive) and currently possesses "good valuation appeal" relative to the broader index. LONG Healthcare (XLV) and specifically Pharmaceuticals (XPH) and Medical Devices (IHI) as a hedge against geopolitical volatility. A rapid de-escalation in the Middle East could trigger a "risk-on" rotation back into Tech, causing defensive sectors to lag.
XPH SPDR S&P Pharmaceuticals ETF Long 1ST — —
Log in to see ideas

About XPH Investor Commentary

Across the available history and selected sources, Buzzberg tracks XPH (SPDR S&P Pharmaceuticals ETF) across 9 sources: 11 bullish vs 0 bearish calls from 19 authors. Historical directional balance: 55% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 20 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: Stephen Carroll, Alejandro Estebaranz, Lori Calvasina.